Bluejay Diagnostics, Inc.

NASDAQ (USD): Bluejay Diagnostics, Inc. (BJDX)

Last Price

3.63

Today's Change

-0.21 (5.46%)

Day's Change

3.25 - 4.04

Trading Volume

88,355

Overview

Market Cap

2 Million

Shares Outstanding

552,854

Avg Volume

635,290

Avg Price (50 Days)

4.50

Avg Price (200 Days)

98.04

PE Ratio

0.00

EPS

-804.00

Earnings Announcement

18-Mar-2025

Previous Close

3.84

Open

3.88

Day's Range

3.25 - 4.04

Year Range

3.03 - 1128.0

Trading Volume

88,360

Price Change Highlight

1 Day Change

-5.47%

5 Day Change

-15.78%

1 Month Change

3.12%

3 Month Change

-49.23%

6 Month Change

-97.59%

Ytd Change

-99.24%

1 Year Change

-99.65%

3 Year Change

-99.99%

5 Year Change

-99.99%

10 Year Change

-99.99%

Max Change

-99.99%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment